Identification of dual cyclooxygenase-eicosanoid oxidoreductase inhibitors: NSAIDs that inhibit PG-LX reductase/LTB(4) dehydrogenase.
暂无分享,去创建一个
[1] C. Serhan,et al. Unorthodox routes to prostanoid formation: new twists in cyclooxygenase-initiated pathways. , 2001, The Journal of clinical investigation.
[2] C. Serhan,et al. Cyclooxygenase-2-Derived Prostaglandin E2 and Lipoxin A4 Accelerate Resolution of Allergic Edema in Angiostrongylus costaricensis-Infected Rats: Relationship with Concurrent Eosinophilia1 , 2000, The Journal of Immunology.
[3] H. Chan,et al. Purification, characterization and selective inhibition of human prostaglandin G/H synthase 1 and 2 expressed in the baculovirus system. , 1994, Biochimica et biophysica acta.
[4] M. Peters-Golden,et al. Granulocyte colony-stimulating factor administration to HIV-infected subjects augments reduced leukotriene synthesis and anticryptococcal activity in neutrophils. , 1998, The Journal of clinical investigation.
[5] T. Kensler,et al. Identification of dithiolethione-inducible gene-1 as a leukotriene B4 12-hydroxydehydrogenase: implications for chemoprevention. , 1998, Carcinogenesis.
[6] H. Tai,et al. 15-Hydroxyprostaglandin dehydrogenase. , 1995, Journal of lipid mediators and cell signalling.
[7] Y. Taketani,et al. Enzymatic inactivation of leukotriene B4 by a novel enzyme found in the porcine kidney. Purification and properties of leukotriene B4 12-hydroxydehydrogenase. , 1993, The Journal of biological chemistry.
[8] S. Mitchell,et al. Lipoxins: revelations on resolution. , 2001, Trends in pharmacological sciences.
[9] Fitzgerald Ga,et al. Selective inhibitors of cyclooxygenase-2: a growing class of anti-inflammatory drugs. , 2001 .
[10] G. Levy. Prostaglandin H synthases, nonsteroidal antiinflammatory drugs, and colon cancer , 1997, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[11] N. Uozumi,et al. cDNA Cloning, Expression, and Mutagenesis Study of Leukotriene B4 12-Hydroxydehydrogenase (*) , 1996, The Journal of Biological Chemistry.
[12] H. Herschman. Recent progress in the cellular and molecular biology of prostaglandin synthesis. , 1998, Trends in cardiovascular medicine.
[13] M. Labrecque,et al. Efficacy of nonsteroidal anti-inflammatory drugs in the treatment of acute renal colic. A meta-analysis. , 1994, Archives of internal medicine.
[14] W. Koopman. Arthritis and allied conditions;: A textbook of rheumatology , 1972 .
[15] C. Clish,et al. Formation of endogenous "antiinflammatory" lipid mediators by transcellular biosynthesis. Lipoxins and aspirin-triggered lipoxins inhibit neutrophil recruitment and vascular permeability. , 2000, American journal of respiratory and critical care medicine.
[16] J. Rokach,et al. Effects of metabolites of leukotriene B4 on human neutrophil migration and cytosolic calcium levels. , 1996, The Journal of pharmacology and experimental therapeutics.
[17] Charles N. Serhan,et al. Lipid mediator class switching during acute inflammation: signals in resolution , 2001, Nature Immunology.
[18] J. Gosselin,et al. Epstein-Barr virus modulates 5-lipoxygenase product synthesis in human peripheral blood mononuclear cells. , 1997, Blood.
[19] H. Hansen. 15-hydroxyprostaglandin dehydrogenase. A review. , 1976, Prostaglandins.
[20] J. Vane,et al. Inflammation and the mechanism of action of anti‐inflammatory drugs , 1987, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[21] G. FitzGerald,et al. COX in a crystal ball: current status and future promise of prostaglandin research. , 2001, The Journal of clinical investigation.
[22] B. Levy,et al. Oxidoreductases in Lipoxin A4 Metabolic Inactivation , 2000, The Journal of Biological Chemistry.
[23] H. Tai,et al. Purification, cDNA cloning and expression of 15-oxoprostaglandin 13-reductase from pig lung. , 1998, The Biochemical journal.